Multidrug-resistant tuberculosis care in the United States.

Multidrug-resistant tuberculosis care in the United States.
复制标题

DOI:
10.5588/ijtld.19.0515
复制
发表时间:
2020-04-01
影响因子:
4
通讯作者:
Goswami, N. D.
Goswami, N. D.
中科院分区:
医学4区
文献类型:
--
作者:
Gobaud, A. N.;Haley, C. A.;Wilson, J. W.;Bhavaraju, R.;Lardizabal, A.;Seaworth, B. J.;Goswami, N. D.

文献摘要

参考文献

被引文献

相似文献

研究结核病卓越中心医疗咨询服务的利用情况,并评估这些服务如何用于耐多药结核病患者。医疗咨询记录在安全数据库中。查询了2013年1月1日至2017年12月31日期间的耐多药结核病咨询数据库。对所有患者进行分析,以评估提供者类型、中心、设置、呼叫年份和患者类型(儿科与成人)。随机选择一个分组进行专题分析。在此期间,这些中心收到了1560份耐多药结核病咨询请求。要求咨询的提供者主要是医生(55%)。大多数请求来自公共卫生部门(64%)和成人患者(80%)。出现了四个主要专题领域:1)耐多药结核病的初步管理,2)耐多药结核病的纵向治疗和并发症,3)耐多药结核病暴露者的管理,以及4)耐多药结核病治疗的完成。通过对这些咨询的分析,可以深入了解所提供的关于耐多药结核病的专家建议的类型。这些发现突出了增加医疗培训和教育可能有助于改善耐多药结核病相关实践的主题。
To examine the utilization of the Tuberculosis (TB) Centers of Excellence (COE) medical consultation service and evaluate how these services were being employed for patients in relation to multidrug-resistant TB (MDR-TB). Medical consults are documented in a secure database. The database was queried for MDR-TB consultations over the period 1 January 2013–31 December 2017. All were analyzed to assess provider type, center, setting, year of call, and type of patient (pediatric vs. adult). A subgroup was randomly selected for thematic analysis. The centers received 1560 MDR-TB consultation requests over this period. Providers requesting consults were primarily physicians (55%). The majority of requests were from public health departments (64%) and for adult patients (80%). Four major topic areas emerged: 1) initial management of MDR-TB, 2) MDR-TB longitudinal treatment and complications, 3) management of persons exposed to MDR-TB, and 4) MDR-TB treatment completion. Analysis of these consultations provides insight into the type of expert advice about MDR-TB that was provided. These findings highlight topics where increased medical training and education may help to improve MDR-TB-related practices.
DOI: 10.1093/bmb/ldh047
发表时间: 2005-01-01
影响因子: 6.7
作者:
Ormerod, LP
通讯作者: Ormerod, LP
DOI: 10.1200/jop.2014.000679
发表时间: 2015-01-01
影响因子: --
作者:
Salami, Aitua C.;Barden, Gala M.;Anaya, Daniel A.
通讯作者: Anaya, Daniel A.
DOI: 10.1159/000048476
发表时间: 1999-01-01
期刊: CHEMOTHERAPY
影响因子: 3.3
作者:
Iseman, MD
通讯作者: Iseman, MD
DOI: 10.1111/j.1475-6773.2006.00684.x
发表时间: 2007-08-01
影响因子: 3.4
作者:
Bradley, Elizabeth H.;Curry, Leslie A.;Devers, Kelly J.
通讯作者: Devers, Kelly J.
DOI: 10.1093/ofid/ofz167
发表时间: 2019-06-01
影响因子: 4.2
作者:
Goswami, Neela D.;Mese, Sundari;Haley, Connie A.
通讯作者: Haley, Connie A.